Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Exchange Rate Effect (2021 - 2024)

Historic Exchange Rate Effect for Seres Therapeutics (MCRB) over the last 4 years, with Q4 2024 value amounting to -$1000.0.

  • Seres Therapeutics' Exchange Rate Effect changed N/A to -$1000.0 in Q4 2024 from the same period last year, while for Sep 2024 it was $2000.0, marking a year-over-year increase of 30000.0%. This contributed to the annual value of -$1000.0 for FY2024, which is 15000.0% down from last year.
  • According to the latest figures from Q4 2024, Seres Therapeutics' Exchange Rate Effect is -$1000.0.
  • Over the past 5 years, Seres Therapeutics' Exchange Rate Effect peaked at $1000.0 during Q4 2022, and registered a low of -$2000.0 during Q3 2022.
  • In the last 4 years, Seres Therapeutics' Exchange Rate Effect had a median value of -$1000.0 in 2021 and averaged -$400.0.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first soared by 20000.0% in 2022, then soared by 15000.0% in 2023.
  • Seres Therapeutics' Exchange Rate Effect (Quarter) stood at -$1000.0 in 2021, then surged by 200.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then tumbled by 200.0% to -$1000.0 in 2024.
  • Its last three reported values are -$1000.0 in Q4 2024, $1000.0 for Q3 2023, and $1000.0 during Q4 2022.